CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition

Published: June 9, 2020 at 12:22 p.m. ET The MarketWatch News Department was not involved in the creation of this content. OXNARD, Jun 09, 2020 (GLOBE NEWSWIRE via COMTEX) — OXNARD, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active…